228 related articles for article (PubMed ID: 16882705)
1. Nef interference with HIV-1-specific CTL antiviral activity is epitope specific.
Adnan S; Balamurugan A; Trocha A; Bennett MS; Ng HL; Ali A; Brander C; Yang OO
Blood; 2006 Nov; 108(10):3414-9. PubMed ID: 16882705
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation.
Balamurugan A; Ali A; Boucau J; Le Gall S; Ng HL; Yang OO
J Virol; 2013 Aug; 87(15):8726-34. PubMed ID: 23740989
[TBL] [Abstract][Full Text] [Related]
3. Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.
Chen DY; Balamurugan A; Ng HL; Cumberland WG; Yang OO
Blood; 2012 Jul; 120(1):100-11. PubMed ID: 22613796
[TBL] [Abstract][Full Text] [Related]
4. Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL.
Yang OO; Sarkis PT; Trocha A; Kalams SA; Johnson RP; Walker BD
J Immunol; 2003 Oct; 171(7):3718-24. PubMed ID: 14500671
[TBL] [Abstract][Full Text] [Related]
5. HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.
Rajapaksa US; Li D; Peng YC; McMichael AJ; Dong T; Xu XN
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13353-8. PubMed ID: 22826228
[TBL] [Abstract][Full Text] [Related]
6. A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients.
Harrer EG; Bergmann S; Eismann K; Rittmaier M; Goldwich A; Müller SM; Spriewald BM; Harrer T
AIDS; 2005 Apr; 19(7):734-5. PubMed ID: 15821402
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
[TBL] [Abstract][Full Text] [Related]
9. Functional adaptation of Nef to the immune milieu of HIV-1 infection in vivo.
Lewis MJ; Balamurugan A; Ohno A; Kilpatrick S; Ng HL; Yang OO
J Immunol; 2008 Mar; 180(6):4075-81. PubMed ID: 18322217
[TBL] [Abstract][Full Text] [Related]
10. Broadly increased sensitivity to cytotoxic T lymphocytes resulting from Nef epitope escape mutations.
Ali A; Pillai S; Ng H; Lubong R; Richman DD; Jamieson BD; Ding Y; McElrath MJ; Guatelli JC; Yang OO
J Immunol; 2003 Oct; 171(8):3999-4005. PubMed ID: 14530319
[TBL] [Abstract][Full Text] [Related]
11. Switching and emergence of CTL epitopes in HIV-1 infection.
Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
[TBL] [Abstract][Full Text] [Related]
12. Cutting Edge: Epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication.
Tomiyama H; Fujiwara M; Oka S; Takiguchi M
J Immunol; 2005 Jan; 174(1):36-40. PubMed ID: 15611225
[TBL] [Abstract][Full Text] [Related]
13. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
[TBL] [Abstract][Full Text] [Related]
15. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
[TBL] [Abstract][Full Text] [Related]
16. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
Hadida F; Haas G; Zimmermann N; Hosmalin A; Spohn R; Samri A; Jung G; Debre P; Autran B
J Immunol; 1995 Apr; 154(8):4174-86. PubMed ID: 7535824
[TBL] [Abstract][Full Text] [Related]
17. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
Ali A; Lubong R; Ng H; Brooks DG; Zack JA; Yang OO
J Virol; 2004 Jan; 78(2):561-7. PubMed ID: 14694087
[TBL] [Abstract][Full Text] [Related]
18. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
Tomiyama H; Akari H; Adachi A; Takiguchi M
J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
[TBL] [Abstract][Full Text] [Related]
19. Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL.
Motozono C; Yanaka S; Tsumoto K; Takiguchi M; Ueno T
J Immunol; 2009 May; 182(9):5528-36. PubMed ID: 19380801
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of HLA-B*5401-restricted HIV-1-Nef and Pol-specific CTL epitopes.
Kitano M; Kobayashi N; Kawashima Y; Akahoshi T; Nokihara K; Oka S; Takighuchi M
Microbes Infect; 2008 Jun; 10(7):764-72. PubMed ID: 18538615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
